NL8501564A - Bepaling voor interferon epsilon. - Google Patents

Bepaling voor interferon epsilon. Download PDF

Info

Publication number: NL8501564A
Authority: NL; Netherlands
Prior art keywords: cells; interferon; sample; virus; epsilon
Prior art date: 1984-07-06

Application number

NL8501564A

Other languages

English (en)

Dutch (nl)

Original Assignee

Damon Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-07-06

Filing date

1985-05-31

Publication date

1986-02-03

1985-05-31 Application filed by Damon Biotech Inc filed Critical Damon Biotech Inc

1986-02-03 Publication of NL8501564A publication Critical patent/NL8501564A/nl

Links

102100026688 Interferon epsilon Human genes 0.000 title claims description 51
101710147309 Interferon epsilon Proteins 0.000 title claims description 51
210000004027 cell Anatomy 0.000 claims description 37
102000014150 Interferons Human genes 0.000 claims description 36
108010050904 Interferons Proteins 0.000 claims description 36
241000700605 Viruses Species 0.000 claims description 27
210000002919 epithelial cell Anatomy 0.000 claims description 25
210000002510 keratinocyte Anatomy 0.000 claims description 23
229940079322 interferon Drugs 0.000 claims description 21
102000006992 Interferon-alpha Human genes 0.000 claims description 19
108010047761 Interferon-alpha Proteins 0.000 claims description 19
210000002950 fibroblast Anatomy 0.000 claims description 19
238000000034 method Methods 0.000 claims description 18
239000000523 sample Substances 0.000 claims description 18
208000015181 infectious disease Diseases 0.000 claims description 16
229940047124 interferons Drugs 0.000 claims description 15
108090000467 Interferon-beta Proteins 0.000 claims description 12
102000003996 Interferon-beta Human genes 0.000 claims description 11
108010074328 Interferon-gamma Proteins 0.000 claims description 8
102000008070 Interferon-gamma Human genes 0.000 claims description 7
239000000203 mixture Substances 0.000 claims description 7
229940044627 gamma-interferon Drugs 0.000 claims description 3
238000011534 incubation Methods 0.000 claims description 3
241000711975 Vesicular stomatitis virus Species 0.000 claims description 2
239000012470 diluted sample Substances 0.000 claims 1
230000000694 effects Effects 0.000 description 20
238000003556 assay Methods 0.000 description 15
230000000840 anti-viral effect Effects 0.000 description 14
238000002360 preparation method Methods 0.000 description 10
238000004113 cell culture Methods 0.000 description 9
OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 8
238000006386 neutralization reaction Methods 0.000 description 7
238000012360 testing method Methods 0.000 description 6
241000711404 Avian avulavirus 1 Species 0.000 description 5
229960001388 interferon-beta Drugs 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
238000001514 detection method Methods 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
229950000038 interferon alfa Drugs 0.000 description 3
239000000463 material Substances 0.000 description 3
241000710188 Encephalomyocarditis virus Species 0.000 description 2
101000836540 Homo sapiens Aldo-keto reductase family 1 member B1 Proteins 0.000 description 2
101000809450 Homo sapiens Amphiregulin Proteins 0.000 description 2
101000928259 Homo sapiens NADPH:adrenodoxin oxidoreductase, mitochondrial Proteins 0.000 description 2
101000635799 Homo sapiens Run domain Beclin-1-interacting and cysteine-rich domain-containing protein Proteins 0.000 description 2
102100030852 Run domain Beclin-1-interacting and cysteine-rich domain-containing protein Human genes 0.000 description 2
239000003443 antiviral agent Substances 0.000 description 2
230000000120 cytopathologic effect Effects 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
210000000981 epithelium Anatomy 0.000 description 2
239000000499 gel Substances 0.000 description 2
102000046818 human AR Human genes 0.000 description 2
229960003130 interferon gamma Drugs 0.000 description 2
239000007758 minimum essential medium Substances 0.000 description 2
230000003472 neutralizing effect Effects 0.000 description 2
238000013207 serial dilution Methods 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
102100026720 Interferon beta Human genes 0.000 description 1
102100037850 Interferon gamma Human genes 0.000 description 1
102000011782 Keratins Human genes 0.000 description 1
108010076876 Keratins Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000711408 Murine respirovirus Species 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
241001122767 Theaceae Species 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
230000032683 aging Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
229940121357 antivirals Drugs 0.000 description 1
239000011324 bead Substances 0.000 description 1
210000003969 blast cell Anatomy 0.000 description 1
UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000007123 defense Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
239000003226 mitogen Substances 0.000 description 1
238000013365 molecular weight analysis method Methods 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
239000005373 porous glass Substances 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
244000144977 poultry Species 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000011403 purification operation Methods 0.000 description 1
239000012521 purified sample Substances 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000012207 quantitative assay Methods 0.000 description 1
230000028327 secretion Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
210000003491 skin Anatomy 0.000 description 1
208000003265 stomatitis Diseases 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000004448 titration Methods 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/811—Interferon
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Pathology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NL8501564A 1984-07-06 1985-05-31 Bepaling voor interferon epsilon. NL8501564A (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US62861284		1984-07-06
US06/628,612 US4675282A (en)	1984-07-06	1984-07-06	Assay for interferon epsilon

Publications (1)

Publication Number	Publication Date
NL8501564A true NL8501564A (nl)	1986-02-03

Family

ID=24519613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8501564A NL8501564A (nl)	1984-07-06	1985-05-31	Bepaling voor interferon epsilon.

Country Status (14)

Country	Link
US (1)	US4675282A (da)
JP (1)	JPS6125060A (da)
AU (1)	AU3857085A (da)
BE (1)	BE902663A (da)
CA (1)	CA1244345A (da)
CH (1)	CH666285A5 (da)
DE (1)	DE3515803A1 (da)
DK (1)	DK99185A (da)
FR (1)	FR2567269A1 (da)
GB (1)	GB2161270A (da)
IT (1)	IT1183809B (da)
NL (1)	NL8501564A (da)
NO (1)	NO850536L (da)
SE (1)	SE8500620L (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1299099C (en) *	1986-03-06	1992-04-21	Paul Richard Wood	In vitro assay for detecting cell-mediated immune responses
EP1037995A1 (en)	1997-12-08	2000-09-27	Genentech, Inc.	Human interferon-epsilon: a type 1 interferon
ZA9811070B (en)	1997-12-08	2000-07-03	Genentech Inc	Type I interferons.
EP2327724A3 (en)	2004-02-02	2011-07-27	Ambrx, Inc.	Modified human growth hormone polypeptides and their uses
NZ586947A (en)	2008-02-08	2012-11-30	Ambrx Inc	Modified leptin polypeptides and their uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1443425A (en) *	1972-10-25	1976-07-21	Searle & Co	Interferon assay
US3910824A (en) *	1973-10-18	1975-10-07	Searle & Co	Interferon assay
US4241174A (en) *	1978-11-24	1980-12-23	Hoffmann-La Roche Inc.	Interferon assay
JPS56135420A (en) *	1980-03-26	1981-10-22	Fumiaki Taguchi	Suppressive substance of virus and its preparation
NO832517L (no) *	1982-07-12	1984-01-13	Damon Biotech Inc	Interferonpreparat, samt fremgangsmaate for dets fremstilling
IL66733A (en) *	1982-09-07	1986-03-31	Yeda Res & Dev	Assay for ifn and kit therefor

1984
- 1984-07-06 US US06/628,612 patent/US4675282A/en not_active Expired - Fee Related
1985
- 1985-02-07 CA CA000473754A patent/CA1244345A/en not_active Expired
- 1985-02-08 AU AU38570/85A patent/AU3857085A/en not_active Abandoned
- 1985-02-12 NO NO850536A patent/NO850536L/no unknown
- 1985-02-12 SE SE8500620A patent/SE8500620L/xx not_active Application Discontinuation
- 1985-03-04 DK DK99185A patent/DK99185A/da not_active Application Discontinuation
- 1985-03-25 JP JP6051285A patent/JPS6125060A/ja active Pending
- 1985-04-30 IT IT67398/85A patent/IT1183809B/it active
- 1985-05-02 DE DE19853515803 patent/DE3515803A1/de not_active Ceased
- 1985-05-31 NL NL8501564A patent/NL8501564A/nl not_active Application Discontinuation
- 1985-06-12 FR FR8508919A patent/FR2567269A1/fr active Pending
- 1985-06-14 BE BE0/215192A patent/BE902663A/fr not_active IP Right Cessation
- 1985-07-05 CH CH2898/85A patent/CH666285A5/de not_active IP Right Cessation
- 1985-07-05 GB GB08517164A patent/GB2161270A/en not_active Withdrawn

Also Published As

Publication number	Publication date
AU3857085A (en)	1986-01-09
JPS6125060A (ja)	1986-02-03
IT8567398A0 (it)	1985-04-30
BE902663A (fr)	1985-09-30
SE8500620L (sv)	1986-01-07
SE8500620D0 (sv)	1985-02-12
NO850536L (no)	1986-01-07
DE3515803A1 (de)	1986-01-16
FR2567269A1 (fr)	1986-01-10
GB2161270A (en)	1986-01-08
DK99185A (da)	1986-01-07
IT8567398A1 (it)	1986-10-30
IT1183809B (it)	1987-10-22
CH666285A5 (de)	1988-07-15
CA1244345A (en)	1988-11-08
GB8517164D0 (en)	1985-08-14
DK99185D0 (da)	1985-03-04
US4675282A (en)	1987-06-23

Legal Events

Date	Code	Title
1986-02-03	A1A	A request for search or an international-type search has been filed
1988-08-01	BB	A search report has been drawn up
1990-01-02	BV	The patent application has lapsed

Publication	Publication Date	Title
Baker et al.	2013	Antiviral immune responses of bats: a review
Ruiz Silva et al.	2016	Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells
King et al.	1971	Polypeptides of the tail fibres of bacteriophage T4
Le Coupanec et al.	2013	Aedes mosquito saliva modulates Rift Valley fever virus pathogenicity
Velazquez-Salinas et al.	2018	Increased virulence of an epidemic strain of vesicular stomatitis virus is associated with interference of the innate response in pigs
Green et al.	1981	Sequential production of IFN-alpha and immune-specific IFN-gamma by human mononuclear leukocytes exposed to herpes simplex virus.
Finter	1964	Quantitative haemadsorption, a new assay technique: I. Assay of interferon
Yeh et al.	1982	Automated, quantitative cytopathic effect reduction assay for interferon
Mariappan et al.	2023	Differential expression of interferon inducible protein: Guanylate binding protein (GBP1 & GBP2) in severe dengue
Vogel et al.	1991	Measurement of antiviral activity induced by interferons α, β, and γ
DE69515416T2 (de)	2000-09-21	Verfahren zum Nachweis von Interferonaktivität
Van Wyk et al.	2016	Induction of functional interferon alpha and gamma responses during acute infection of cattle with non-cytopathic bovine viral diarrhea virus
Evans et al.	2022	Differences in neuroinvasion and protective innate immune pathways between encephalitic California Serogroup orthobunyaviruses
NL8501564A (nl)	1986-02-03	Bepaling voor interferon epsilon.
Bustos-Arriaga et al.	2016	Soluble mediators produced by the crosstalk between microvascular endothelial cells and dengue-infected primary dermal fibroblasts inhibit dengue virus replication and increase leukocyte transmigration
Meager	2004	Assays for antiviral activity
Hussain et al.	2021	Atopic neutrophils prevent postviral airway disease
Grossberg et al.	1984	Assay of interferons
Cray et al.	2005	Serologic diagnosis of sarcocystosis in psittacine birds: 16 cases
Gates et al.	2009	Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry
Eruznannx et al.	1985	Inapparent infections of brown trout with VHS-virus
Marcus et al.	1992	Interferon induction by viruses. XXI. Vesicular stomatitis virus: interferon inducibility as a phylogenetic marker
Richtsmeier	1983	Human interferon production in tonsil and adenoid tissue cultures
Argyle et al.	1998	Expression of feline recombinant interferon-γ in baculovirus and demonstration of biological activity
DE69629121T2 (de)	2004-05-27	Verwendung eines 24 kD Proteins zur Behandlung und Diagnose einer HCV Infektion